InsiderTrades

Form 4 for ANIK Anika Therapeutics, Inc.

Accepted 2025-03-11 00:00:00 ET · period of report 2025-03-10 · accession 0001171843-25-001404 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-03-11 2025-03-10 ANIK Blanchard Cheryl R Pres, CEO, Dir F - Tax $16.62 -5,871 167.0K -3% -$97.6K
D 2025-03-11 2025-03-10 ANIK Blanchard Cheryl R Pres, CEO, Dir M - OptEx $0.00 +20.0K 172.8K +13% $0
D 2025-03-11 2025-03-10 ANIK Blanchard Cheryl R Pres, CEO, Dir M - OptEx $0.00 -20.0K 20.0K -50% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-03-10 F D 5,871 $16.62 166,955 D — — (F3) Reflects an aggregate of 5,871 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2025. (F4) Reflects the closing price of ANIK common stock on March 7, 2025, the trading day prior to which the vesting of RSUs gave rise to tax withholding obligations.
2 Common Common Stock 2025-03-10 M A 20,002 $0.00 172,826 D — — (F1) Reflects the second vesting installment of RSUs granted on March 9, 2023. (F2) Includes the following shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan: 800 shares purchased on May 14, 2024 and 330 shares purchased on November 14, 2024.
3 Derivative Restricted Stock Unit 2025-03-10 M D 20,002 $0.00 20,001 D $0.00 · — to — 20,002 Common Stock (F6) Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2024.